Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Keensight Capital S.A.S.

Keensight Capital, one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. For 20 years, Keensight Capital’s team of seasoned professionals has leveraged their knowledge of investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million. Drawing on its expertise in the Information Technology/Internet and Healthcare/Wellbeing sectors, Keensight identifies the best investment opportunities in Europe and works closely with management teams to develop and achieve their strategic vision. *

 

Period Start 2019-07-23 existent
Products Industry private equity
  Industry 2 LIFE SCIENCES
Persons Person Rémy, Pierre (Keensight Capital 201907 Managing Partner)
  Person 2 Moses, Edwin (Ablynx 200603– CEO before non-exec Board Member 200411– before Oxford Asymmetry)
     
Region Region Paris
  Country France
  Street 64 rue de Lisbonne
  City 75008 Paris
  Tel +33-1-8379-8730
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris.
     
   
Record changed: 2024-02-12

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Keensight Capital S.A.S.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px




» top